click below
click below
Normal Size Small Size show me how
BS2014 - drugs
All the drugs from the BS2014 module at the University of Leicester
Drug | Disorder/mechanism of action |
---|---|
Aspirin, paracetamol, ibuprofen, etc | Pain - inhibit cox enzymes from converting arachidonic acid to prostaglandins |
Diazepam | Anxiety, insomnia - GABAa receptor agonist (sustained) |
Alprazolam | Anxiety, insomnia - GABAa receptor agonist (sustained) |
Chlordiazepoxide | Anxiety, insomnia - GABAa receptor agonist (sustained) |
Clobazam | Anxiety, insomnia - GABAa receptor agonist (sustained) |
Lorazepam | Anxiety, insomnia - GABAa receptor agonist (short acting) |
Oxazepam | Anxiety, insomnia - GABAa receptor agonist (short acting) |
Buspirone | Anxiety - serotonin receptor agonist |
Propranolol | Anxiety - beta-blocker |
Oxprenolol | Anxiety - beta-blocker |
Phenytoin | Epilepsy - use dependent block of sodium channels |
Carbamazepine | Epilepsy - use dependent block of sodium channels |
Phenobarbital | Epilepsy - GABAa receptor agonist |
Primidone | Epilepsy - GABAa receptor agonist |
Vigabatrin | Epilepsy - inhibits GABA aminotransferase, and hence GABA breakdown |
Clomipramine | Depression - inhibit noradrenaline and serotonin reuptake (tricyclic antidepressants) |
Doxepin | Depression - inhibit noradrenaline and serotonin reuptake (tricyclic antidepressants) |
Trimipramine | Depression - inhibit noradrenaline and serotonin reuptake (tricyclic antidepressants) |
Imipramine | Depression - inhibit noradrenaline and serotonin reuptake (tricyclic antidepressants) |
Lofepramine | Depression - inhibit noradrenaline and serotonin reuptake (tricyclic antidepressants) |
Nortriptyline | Depression - inhibit noradrenaline and serotonin reuptake (tricyclic antidepressants) |
Citalopram | Depression - selective serotonin re-uptake inhibitor (SSRI) |
Escitalopram | Depression - selective serotonin re-uptake inhibitor (SSRI) |
Fluoxetine | Depression - selective serotonin re-uptake inhibitor (SSRI) |
Fluvoxamine | Depression - selective serotonin re-uptake inhibitor (SSRI) |
Paroxetine | Depression - selective serotonin re-uptake inhibitor (SSRI) |
Sertraline | Depression - selective serotonin re-uptake inhibitor (SSRI) |
Duloxetine | Depression - serotonin - noradrenaline(norepinephrine) re-uptake inhibitor (SNRI) |
Venlafaxine | Depression - serotonin - noradrenaline(norepinephrine) re-uptake inhibitor (SNRI) |
Phenelzine | Depression - irreversible MAO inhibitor |
Isocarboxazid | Depression - irreversible MAO inhibitor |
Tranylcypromine | Depression - irreversible MAO inhibitor |
Moclobemide | Depression - reversible MAO inhibitor |
Mirtrazapine | Depression - alpha2-adrenoceptor antagonist |
Lithium carbonate | Manic depression/bipolar disorder - uncompetitively inhibits inositol monophosphatase |
Lithium citrate | Manic depression/bipolar disorder - uncompetitively inhibits inositol monophosphatase |
Amphetamine | Narcolepsy, ADHD - taken up by noradrenaline uptake 1, packaged into vesicles, inhibits MAO, acts weakly on adrenoceptors (also used recreationally) |
Cocaine | Mostly used recreationally, also used as a local anaesthetic - blocks re-uptake of noradrenaline, dopamine and serotonin |
Chlorpromazine | Psychosis - D2 receptor antagonist |
Levomepromazine | Psychosis - D2 receptor antagonist |
Pericyazine | Psychosis - D2 receptor antagonist |
Pipotiazine | Psychosis - D2 receptor antagonist |
Fluphenazine | Psychosis - D2 receptor antagonist |
Perphenazine | Psychosis - D2 receptor antagonist |
Prochlorperazine | Psychosis - D2 receptor antagonist |
Trifluoperazine | Psychosis - D2 receptor antagonist |
Clozapine | Psychosis - D2 receptor antagonist |
Olanzapine | Psychosis - D2 receptor antagonist |
Phencyclidine | Mostly recreational - NMDA receptor blocker (aka "angel dust") |
Ketamine | Mostly recreational - NMDA receptor blocker |
Morphine | Pain - agonist for opioid receptors, particularly mu receptor |
Heroin | Mostly recreational - opioid receptor agonist, particularly mu receptor |
Naloxone | Heroin overdose - high affinity competitive mu opioid receptor antagonist |
Buprenorphine | Heroin addiction - partial mu opioid receptor antagonist |
L-DOPA | Parkinson's disease - increases rate of dopamine synthesis by replacing DOPA |
Carbidopa | Parkinson's disease (used to optimise L-DOPA treatment) - inhibits peripheral DOPA decarboxylase |
Benserazide | Parkinson's disease (used to optimise L-DOPA treatment) - inhibits peripheral DOPA decarboxylase |
Selegiline | Parkinson's disease (used to optimise L-DOPA treatment) - inhibits MAO-B |
Entacapone | Parkinson's disease (used to optimise L-DOPA treatment) - inhibits COMT |
Domperidone | Parkinson's disease (used to optimise L-DOPA treatment) - blocks peripheral dopamine receptors |
Bromocriptine | Parkinson's disease - dopamine receptor agonist |
Lisuride | Parkinson's disease - dopamine receptor agonist |
Pergolide | Parkinson's disease - dopamine receptor agonist |